
Ubigene gene knockout cell lines mediated by optimized CRISPR-Cas9 technology provide reliable in vitro models for investigating gene function, signaling pathways, disease mechanisms, and therapeutic targets.
BACH1 (BTB domain and CNC homolog 1) encodes a CNC-bZIP transcription factor containing BTB/POZ domains that facilitate protein-protein interactions and oligomerization. BACH1 forms heterodimers with MafK and can repress transcription from Maf recognition elements. Through DNA binding and recruitment of transcriptional regulatory complexes, BACH1 regulates gene expression programs responsive to cellular and environmental signals. Its transcriptional activity is relevant to processes including oxidative stress responses, cellular differentiation, and regulation of metabolic and inflammatory pathways.
Human cervical squamous carcinoma cells containing an integrated HPV16 genome are represented by Siha. The line was established from the cervix of a 55-year-old woman and is classified as an HPV16-related cervical squamous cell carcinoma. Its HPV16 genome contains a disruption of the E2 region and a small deletion, while the cells exhibit microsatellite stability.
Before delivery, each clone is authenticated by STR, tested for sterility and mycoplasma, and genotype‑verified by two‑round PCR‑sequencing. Comprehensive QC data accompany every shipment to support reproducible research.

Cas9 cell lines in our cell bank can stably express Cas9 protein. Each Cas9 Stable Cell Line is easy to use and enables gene knockout simply by transfecting gRNA, while transfection of gRNA and donor DNA results in gene knock-in or point mutations
These Cas9 stable cell lines have been used to construct the KO cell lines for various genes, gene KO efficiency 5-10 times improved.
Selected cells, low passages, good cell condition, high activity, applicable for all kinds of gene-editing experiments.
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use





Simply fill out the form below to leave your inquiry
— we will respond within 24 Hours.
* Name
* Institution
* Products & Services of Interest
If email is not available, how else can we reach you?
How did you hear about us?